본문으로 바로가기
Product Thumnail Image
Product Thumnail Image
Product Thumnail Image
Product Thumnail Image
Product Thumnail Image
Product Thumnail Image

2 ZISHEL GROUP

KITA DUNS

Country South Korea South Korea

Supplier Grade level3

Main products ZISHÉL® HA Filler
TESSLIFT THREAD, PDO THREAD, FACE LIFTING, MESO THREAD
ESTHERACTION V MASK
ESTHERACTION PDRN AMPOULE SKIN CARE

Product Information

ZISHÉL® is used for temporary improvement of wrinkles by injecting it into the skin layer around the facial wrinkles. It is a colorless and transparent gel-type product with viscoelasticity composed of hyaluronic acid of non-animal origin.

 

ZISHÉL® is manufactured by the CHA Group (Top leader in pharma and stem cell and has 26 units of hospitals, medical universities, stem cell banks, and research labs located in the U.S., Japan and South Korea). The CHA Group also has its own premium aesthetic medical facility well-known as the luxurious anti-aging field, the CHA Group manufactures the most premium, biocompatible, and effective hyaluronic acid dermal filler.

 

editorimg

 

editorimg 


editorimg


editorimg

Image
  • ZISH_L_ HA Filler with Lidocaine

  • ZISH_L_ HA Filler with Lidocaine

  • ZISH_L_ HA Filler

  • ZISH_L_ HA Filler

  • ZISH_L_ HA Filler

Company
ZISHEL GROUP

ZISHEL GROUP

Country South Korea South Korea

Supplier Grade level3

President
Jimmy JW Kim
Address
907, Eon-ju ro 201, Gangnam-gu, Seoul, Korea
Product Category
Medical Devices
Year Established
2016
No. of Total Employees
51-100
Company introduction
ZISHEL GROUP was established to R&D, market, and distribute the novel medical technologies for Plastic, Reconstruction, and Aesthetics. In connection with more than 23 international medical chains and +11,450 private clinics, we have the mega-size distribution channels in over 54 countries covered by +35 blockbuster distributors worldwide. The majority of our executives were both educated and trained in the United States. They lead to excellence via unique leadership styles over our staffs and have propitious relationships with internationally recognized professors, physicians, and healthcare professionals worldwide. Our key differentiator is our continued investments for R&D activities under a variety of applications. In the fast-changing healthcare environment, we challenge ourselves to adapt to new trends and lead developments for novel solutions tailored to our clients' needs.
Main Markets
  • Brunei Brunei ,
  • Canton&E. Is Canton&E. Is ,
  • Indonesia Indonesia ,
  • Cambodia Cambodia